Please try another search
Berenberg Bank analyst Zhiqiang Shu maintained a Buy rating on Morphosys Ag (NASDAQ:MOR) on Wednesday, setting a price target of EUR140, which is approximately 631.86% above the present share price of $22.76.
Shu expects Morphosys Ag to post earnings per share (EPS) of $0.00 for the first quarter of 2021.
The current consensus among 1 TipRanks analysts is for a Moderate Buy rating of shares in Morphosys Ag, with an average price target of $166.57.
The analysts price targets range from a high of $166.57 to a low of $166.57.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $22 million and a net profit of -$62.03 million. The company's market cap is $2.98 billion.
According to TipRanks.com, Berenberg Bank analyst Zhiqiang Shu is currently ranked with 2 stars on a 0-5 stars ranking scale, with an average return of 5.4% and a 37.04% success rate.
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery (NASDAQ:DISCA) segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.